ProQR Therapeutics N.V (PRQR) Wheel Strategy

Running a PRQR wheel strategy lets you generate consistent premium income on ProQR Therapeutics N.V while setting your own entry and exit prices on the underlying. ProQR Therapeutics N.V's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own PRQR, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best PRQR wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on PRQR, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable PRQR wheel from a losing one.

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in the developing of Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system.

ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the PRQR wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your PRQR wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.